[Lipoprotein lipase inhibitory factor].
Kihara
S
S
Second Department of Internal Medicine, Osaka University Medical School.
D000328:Adult; D000818:Animals; D053304:Apolipoprotein C-II; D001056:Apolipoproteins C / Q000276:immunology; D001161:Arteriosclerosis / Q000209:etiology; D001323:Autoantibodies; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000175:diagnosis / Q000209:etiology*; D007136:Immunoglobulins / Q000378:metabolism; D008071:Lipoprotein Lipase / Q000276:immunology*; D008077:Lipoproteins, LDL / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011973:Receptors, LDL / Q000276:immunology / Q000378:metabolism
D053304:Apolipoprotein C-II; D001056:Apolipoproteins C; D001323:Autoantibodies; D007136:Immunoglobulins; D008077:Lipoproteins, LDL; D011973:Receptors, LDL; D008071:Lipoprotein Lipase